BIOCLINICA INC Operating Cash Flow
BIOCLINICA INC reported Operating Cash Flow of $9.85 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2013-02-22
- BIOCLINICA INC net cash provided by (used in) operating activities for the quarter ending 2012-12-31 was $3.84M, a 110.59% increase year-over-year.
- BIOCLINICA INC net cash provided by (used in) operating activities for the quarter ending 2012-09-30 was $2.88M, a 28.54% increase year-over-year.
- BIOCLINICA INC net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was $1.79M, a 28.29% decline year-over-year.
- BIOCLINICA INC net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was $1.35M, a 15.24% increase year-over-year.
- BIOCLINICA INC net cash provided by (used in) operating activities for fiscal 2012 was $9.85M, a 27.53% increase from fiscal 2011.
- BIOCLINICA INC net cash provided by (used in) operating activities for fiscal 2011 was $7.73M, a 93.54% increase from fiscal 2010.
- BIOCLINICA INC net cash provided by (used in) operating activities for fiscal 2010 was $3.99M, a 47.14% decline from fiscal 2009.
- BIOCLINICA INC net cash provided by (used in) operating activities for fiscal 2009 was $7.55M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2012-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $6.72M derived: sum of 2 quarters · filed 2013-02-22 | $8.51M derived: sum of 3 quarters · filed 2013-02-22 | $9.85M 10-K · filed 2013-02-22 | |
| 2012-09-30 | $2.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $4.67M derived: sum of 2 quarters · filed 2012-11-09 | $6.01M 10-Q · filed 2012-11-09 | $7.84M derived: sum of 4 quarters · filed 2013-02-22 | |
| 2012-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $3.14M 10-Q · filed 2012-08-09 | $4.96M derived: sum of 3 quarters · filed 2013-02-22 | $7.20M derived: sum of 4 quarters · filed 2013-02-22 | |
| 2012-03-31 | $1.35M 10-Q · filed 2012-05-10 | $3.17M derived: sum of 2 quarters · filed 2013-02-22 | $5.41M derived: sum of 3 quarters · filed 2013-02-22 | $7.90M derived: sum of 4 quarters · filed 2013-02-22 | |
| 2011-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $4.06M derived: sum of 2 quarters · filed 2013-02-22 | $6.56M derived: sum of 3 quarters · filed 2013-02-22 | $7.73M 10-K · filed 2013-02-22 | |
| 2011-09-30 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $4.74M derived: sum of 2 quarters · filed 2012-11-09 | $5.90M 10-Q · filed 2012-11-09 | $6.82M derived: sum of 4 quarters · filed 2013-02-22 | |
| 2011-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $3.66M 10-Q · filed 2012-08-09 | $3.28M 10-Q · filed 2011-08-08 | $4.58M derived: sum of 3 quarters · filed 2013-02-22 | $5.82M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-03-31 | $1.17M 10-Q · filed 2012-05-10 | $2.09M derived: sum of 2 quarters · filed 2013-02-22 | $3.33M derived: sum of 3 quarters · filed 2013-02-22 | ||
| 2010-12-31 | $919.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $2.16M derived: sum of 2 quarters · filed 2013-02-22 | $3.99M 10-K · filed 2013-02-22 | ||
| 2010-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $3.07M 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $1.83M 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | $7.55M 10-K · filed 2012-02-27 |